3222 Federal Register / Vol. 90, No. 8 / Tuesday, January 14, 2025 / Notices 

researchers or CMS contractors request 

CMS PII/PHI data, they enter into a Data 

Use Agreement (DUA) with CMS. The 

DUA stipulates that the recipient of 

CMS data must properly protect the data 

according to all applicable data security 

standards and provide for its 

appropriate destruction at the 

completion of the project/study or the 

expiration date of the DUA. 

CMS is permitted to disclose data files 

for approved research purposes in 

compliance with 45 CFR 164.512(I). 

Researchers requesting limited data set 

files (LDS) must, as part of the request 

process, complete a research request 

packet that provides CMS with 

information pertaining to the research 

study, including describing how the 

research results/findings will be 

disseminated, as well as the data files 

being requested. Should CMS approve 

the research request, the data requestor 

enters into a Data Use Agreement 

(DUA). This data collection is necessary 

to ensure that disclosures of data for 

research purposes comply with Federal 

laws and regulations as well as CMS 

policy. Form Number: CMS–R–235 

(OMB control number 0938–0734); 

Frequency: Occasionally; Affected 

Public: Private Sector—State, Local, or 

Tribal Governments; and Business or 

other for-profits, Not-for-profits 

institutions and Federal Government 

Number of Respondents: 7,805; Total 

Annual Responses: 7,805; Total Annual 

Hours: 4,234. (For policy questions 

regarding this collection contact 

Rebecca Dorman at 410–786–2095 or 

rebecca.dorman@cms.hhs.gov.) 

3. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Administrative 

Simplification HIPAA Compliance 

Review; Use: The purpose of this 

collection is to retrieve information 

necessary to conduct a compliance 

review and carry out the authority 

delegated to CMS as described in CMS– 

0014–N (68 FR 60694). These forms will 

be submitted to the Centers for Medicare 

& Medicaid Services (CMS), National 

Standards Group, from entities covered 

by HIPAA Administrative 

Simplification regulations. This 

collection is not applicable to HIPAA 

Privacy and Security Rules. Form 

Number: CMS–10662 (OMB control 

number 0938–1390); Frequency: 

Annually; Affected Public: Private 

Sector—State, Local, or Tribal 

Governments; and Business or other forprofits, Not-for-profits institutions and 

Federal Government; Number of 

Respondents: 100; Total Annual 

Responses: 140; Total Annual Hours: 

3,040. (For policy questions regarding 

this collection contact Kevin Stewart at 

410–786–6149 or Kevin.stewart@

cms.hhs.gov.) 

William N. Parham, III, 

Director, Division of Information Collections 

and Regulatory Impacts, Office of Strategic 

Operations and Regulatory Affairs. 

[FR Doc. 2025–00593 Filed 1–13–25; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10203] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by February 13, 2025. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires Federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Medicare Health 

Outcomes Survey; Use: The HOS is a 

longitudinal patient-reported outcome 

measure (PROM) that assesses selfreported beneficiary quality of life and 

daily functioning. As a PROM, the HOS 

measures the impact of services 

provided by MAOs, whereas process 

and patient experience measures only 

provide a snapshot of activities or 

experiences at a specific point in time. 

PROM data collected by the HOS allows 

CMS to continue to assess the health of 

the Medicare Advantage population. 

This older population is at increased 

risk of adverse health outcomes, 

including chronic diseases and mobility 

impairments that may significantly 

hamper quality of life. The HOS 

supports CMS’s commitment to improve 

health outcomes for beneficiaries while 

reducing burden on providers. CMS 

accomplishes this by focusing on highpriority areas for quality measurement 

and improvement established in the 

agency’s Meaningful Measures 

Framework. The HOS uses quality 


khammond on DSK9W7S144PROD with NOTICES
Federal Register / Vol. 90, No. 8 / Tuesday, January 14, 2025 / Notices 3223 

measures that ask beneficiaries about 

health outcomes related to specific 

mental and Physical Conditions. Form 

Number: CMS–10203 (OMB control 

number: 0938–0701); Frequency: Yearly; 

Affected Public: Individuals and 

Households; Number of Respondents: 

1,275; Total Annual Responses: 

663,150; Total Annual Hours: 212,208. 

(For policy questions regarding this 

collection contact Alyssa Rosen at 410– 

786–8559 or Alyssa.Rosen@

cms.hhs.gov.) 

William N. Parham, III 

Director, Division of Information Collections 

and Regulatory Impacts, Office of Strategic 

Operations and Regulatory Affairs. 

[FR Doc. 2025–00589 Filed 1–13–25; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3472–N] 

Medicare Program; Request for 

Nominations for Members for the 

Medicare Evidence Development & 

Coverage Advisory Committee 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Department 

of Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice announces the 

request for nominations for membership 

on the Medicare Evidence Development 

& Coverage Advisory Committee 

(MEDCAC). Among other duties, the 

MEDCAC provides advice and guidance 

to the Secretary of the Department of 

Health and Human Services (the 

Secretary) and the Administrator of the 

Centers for Medicare & Medicaid 

Services (CMS) concerning the 

adequacy of scientific evidence 

available to CMS in making coverage 

determinations under the Medicare 

program. 

The MEDCAC’s fundamental purpose 

is to support the principles of an 

evidence-based determination process 

for Medicare’s coverage policies. 

MEDCAC panels provide advice to CMS 

on the strength of the evidence available 

for specific medical treatments and 

technologies through a public, 

participatory, and accountable process. 

DATES: Nominations must be received 

by Monday, February 17, 2025. 

ADDRESSES: You may send in 

nominations for membership via email 

to MEDCACnomination@cms.hhs.gov. 

FOR FURTHER INFORMATION CONTACT: 

Leah Cromwell, 410–786–2243, 

MEDCAC Coordinator, via email at 

Leah.Cromwell1@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Secretary signed the initial 

charter for the Medicare Coverage 

Advisory Committee (MCAC) on 

November 24, 1998. A notice in the 

Federal Register (63 FR 68780) 

announcing establishment of the MCAC 

was published on December 14, 1998. 

The MCAC name was updated to more 

accurately reflect the purpose of the 

committee and on January 26, 2007, the 

Secretary published a notice in the 

Federal Register (72 FR 3853), 

announcing that the Committee’s name 

changed to the Medicare Evidence 

Development & Coverage Advisory 

Committee (MEDCAC). The current 

Secretary’s Charter for the MEDCAC is 

available on the CMS website at: https:// 

www.cms.gov/Regulations-andGuidance/Guidance/FACA/Downloads/ 

medcaccharter.pdf or you may obtain a 

copy of the charter by submitting a 

request to the contact listed in the FOR

FURTHER INFORMATION section of this 

notice. 

The MEDCAC is governed by 

provisions of the Federal Advisory 

Committee Act, Pub. L. 92–463, as 

amended (5 U.S.C. App. 2), which sets 

forth standards for the formulation and 

use of advisory committees, and is 

authorized by section 222 of the Public 

Health Service Act as amended (42 

U.S.C. 217A). 

We are requesting nominations for 

candidates to serve on the MEDCAC. 

Nominees are selected based upon their 

individual qualifications and not solely 

as representatives of professional 

associations or societies. We wish to 

ensure adequate representation of those 

enrolled in the Medicare program 

including but not limited to, racial and 

ethnic groups, individuals with 

disabilities, and from across the gender 

spectrum. Therefore, we encourage 

nominations of qualified candidates 

who can represent these lived 

experiences. 

The MEDCAC consists of a pool of 

100 appointed members including: 90 

at-large standing members (20 of whom 

are patient advocates), and 10 

representatives of industry interests. 

Members generally are recognized 

authorities in clinical medicine 

including subspecialties, administrative 

medicine, public health, biological and 

physical sciences, epidemiology and 

biostatistics, clinical trial design, health 

care data management and analysis, 

patient advocacy, health care 

economics, health disparities, medical 

ethics, geriatrics those with an 

understanding of sociodemographic bias 

and resulting limitations of scientific 

evidence, or other relevant professions. 

The MEDCAC works from an agenda 

provided by the Designated Federal 

Official. The MEDCAC reviews and 

evaluates medical literature and 

technology assessments, and hears 

public testimony on the evidence 

available to address the impact of 

medical items and services on health 

outcomes of Medicare beneficiaries. The 

MEDCAC may also advise the Centers 

for Medicare & Medicaid Services (CMS) 

as part of Medicare’s ‘‘coverage with 

evidence development’’ initiative. 

II. Provisions of the Notice 

As of December 2025, there will be a 

total of 20 membership terms expiring. 

Of the 20 memberships expiring, 2 are 

industry representatives, 10 are patient 

advocates and the remaining 8 

membership openings are for the atlarge standing MEDCAC membership. 

All nominations must be 

accompanied by curricula vitae. 

Nomination packages should be 

addressed to Leah Cromwell and sent to 

the email address listed in the 

ADDRESSES section of this notice. 

Nominees are selected based upon their 

individual qualifications. 

Nominees for membership must have 

expertise and experience in one or more 

of the following fields: 

• Clinical medicine including 

subspecialties 

• Administrative medicine 

• Public health 

• Health disparities 

• Biological and physical sciences 

• Epidemiology and biostatistics 

• Clinical trial design 

• Health care data management and 

analysis 

• Patient advocacy 

• Health care economics 

• Medical ethics 

• Geriatrics 

• Other relevant professions 

We are looking particularly for 

experts in a number of fields. These 

include health disparities, cancer 

screening, genetic testing, clinical 

epidemiology, psychopharmacology, 

screening and diagnostic testing 

analysis, and vascular surgery. We also 

need experts in biostatistics in clinical 

settings, dementia treatment, 

observational research design, stroke 

epidemiology, geriatrics, and women’s 

health. 

The nomination letter must include a 

statement that the nominee is willing to 

serve as a member of the MEDCAC and 


khammond on DSK9W7S144PROD with NOTICES